8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 17, 2012)

Filed October 17, 2012For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 17, 2012, to report its financial results for the quarter ended September 30, 2012. The primary purpose of this filing is to disseminate the information contained within their accompanying press release, which details the company's performance during the period. Investors should refer to the attached press release (Exhibit 99.1) for specific financial figures, operational performance, and any forward-looking statements made by the company. This 8-K serves as an official notification of the financial outcomes for the third quarter of 2012. While the 8-K itself does not contain the detailed financial statements, it directs investors to the press release where this crucial information is presented. Therefore, a thorough review of Exhibit 99.1 is essential for a comprehensive understanding of Quest Diagnostics' financial condition and operational results for the period.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on October 17, 2012.
  • 2The filing announces results for the quarter ended September 30, 2012.
  • 3The press release containing the financial results is attached as Exhibit 99.1.
  • 4This is a standard disclosure event for reporting quarterly financial performance.
  • 5Investors should consult Exhibit 99.1 for detailed financial information.
  • 6The filing confirms the company's adherence to SEC reporting requirements.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and disseminate Quest Diagnostics' financial results for the third quarter ended September 30, 2012, through an attached press release.

The detailed financial results are located in the press release filed as Exhibit 99.1 to this 8-K. You should refer to this exhibit for specific financial performance data.

No, the 8-K filing itself typically does not contain the full financial statements. It serves as a notification and includes a press release (Exhibit 99.1) which holds the summarized results and key financial figures for the quarter.

This filing is significant for investors as it provides timely information about Quest Diagnostics' financial performance during the reported quarter. It allows investors to assess the company's current financial health and operational trends.